At the same time, ISRG also announced an “Extended Use Program” set to launch in the fourth quarter, which will introduce select Xi/X instruments with 12 – 18 uses compared to 10 today.According to the analyst, company commentary suggests ongoing uncertainty in capital sales and procedure volume outlook.